The results of the RIP assay demonstrated that both miR-28-5p and HIF-1α were enriched in the anti-Ago2 group compared with that in the anti-IgG group (Figure 5c), suggesting the target interaction between miR-28-5p and HIF-1α in NSCLC cells. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.